 |
"Our ambitions are great. We are working on changing the clinical practice in the largest established screening market in oncology with our diagnostic products. Wellington believed in our plan and management team and they are very supportive."
Bob Silverman
CEO, mtm laboratories
Wellington contact:
Rainer Strohmenger
Detect cervical cancer as early as possible
mtm laboratories AG specializes in the development and marketing of products for the early detection, diagnosis, and prevention of cervical cancer, the second most common cancer in women. The company owns the rights for p16, a biomarker that is highly specific for cervical cancer, and has already developed and launched several diagnostic products based on this technology. mtm operates on a global basis with headquarters in Heidelberg, Germany and subsidiaries in the US, France, Italy and Spain. mtm laboratories was founded in August 1999 as a spin-off from the German Center for Cancer Research (DKFZ) in Heidelberg.
First investment: September 2003
mtm laboratories AG
BioPark, Im Neuenheimer Feld 583
69120 Heidelberg
Germany
